Medifast (MED) Amortization of Deferred Charges (2016 - 2022)

Medifast has reported Amortization of Deferred Charges for 5 years, with the latest figure at $3000.0 in Q2 2022.

• For the quarter ending Q2 2022, Amortization of Deferred Charges changed N/A year-over-year to $3000.0; the trailing twelve-month figure through Mar 2023 stood at $3000.0 (down 99.27% YoY), and the FY2022 full-year result was $14000.0, down 84.27% from the prior year.
• Amortization of Deferred Charges for Q2 2022 stood at $3000.0, down from $11000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $153000.0 in Q1 2018, with the low at $3000.0 in Q2 2022.
• Historically, Amortization of Deferred Charges has averaged $102000.0 across 3 years, with a median of $136000.0 in 2018.
• The largest YoY upside for Amortization of Deferred Charges was 12.18% in 2018 against a maximum downside of 21.39% in 2018.
• Medifast's Amortization of Deferred Charges stood at $137000.0 in 2018, then fell by 5.84% to $129000.0 in 2019, then tumbled by 97.67% to $3000.0 in 2022.
• The last three Amortization of Deferred Charges figures came in at $3000.0 (Q2 2022), $11000.0 (Q1 2022), and $129000.0 (Q1 2019), per Business Quant data.